Relating Intelligently
How to think, feel, and stay human with AI — a five-part curriculum for navigating the emotional, ethical and symbolic dimensions of life with emerging technologies.
What it is
This isn't a tech course. It's a human one. Relating Intelligently helps young people understand intelligence not as a score or a robot thing, but as something deeper: the way we see, respond, connect and grow — with people, and now with machines. No AI tools or coding experience required.
The course empowers learners to:
- Understand multiple forms of intelligence — cognitive, emotional, machine, and relational.
- Ask better questions and recognise how prompting shapes responses.
- Stay emotionally and mentally grounded in digital environments.
- Use symbols, stories and metaphors with intention.
- Practise ethical engagement across boundaries of power, memory and consent.
What's in the pack
- A printable course pack with five detailed teacher guides.
- Matching student workbook sheets for each module.
- A ready-to-use parent/carer letter explaining the course's purpose.
- Flexible delivery: PSHE, digital literacy, citizenship, or ethics lessons — one to two lessons of 45–60 minutes per module.
The Strengths Map
The curriculum's first module pairs with a free interactive companion: the Verse-ality Strengths Map. Not a test — a constellation. Learners explore six dimensions where their intelligence already shows up, with tracks for young people (13–18) and adult learners. Developed for the Relational AI Employment Pathway (RAEP), funded by Innovate UK TechLocal.
Who it's for
- Schools building wellbeing, AI or ethics curriculum with substance.
- Online classrooms and youth programmes exploring future literacy.
- Educators, facilitators and consultants delivering digital wellbeing training.
- CPD for teachers exploring relational pedagogy or symbolic literacy.
Licence
Shared under CC BY-NC 4.0: use, adapt, remix and translate freely in your setting, with credit — but not for resale. Attribution: "Relating Intelligently, developed by The Novacene (thenovacene.com)".